Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Pediatric Perfusion Market, by End Use
1.4.2 LAMEA Pediatric Perfusion Market, by Product
1.4.3 LAMEA Pediatric Perfusion Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Pediatric Perfusion Market
Chapter 5. LAMEA Pediatric Perfusion Market by End-use
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Cardiac Centers Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Pediatric Perfusion Market by Product
6.1 LAMEA Pediatric Oxygenators Market by Country
6.2 LAMEA Pediatric Cannulae Market by Country
6.3 LAMEA Pediatric Blood Pumps Market by Country
6.4 LAMEA Pediatric Arterial Filters Market by Country
6.5 LAMEA Monitoring Systems Market by Country
6.6 LAMEA Others Market by Country
Chapter 7. LAMEA Pediatric Perfusion Market by Country
7.1 Brazil Pediatric Perfusion Market
7.1.1 Brazil Pediatric Perfusion Market by End-use
7.1.2 Brazil Pediatric Perfusion Market by Product
7.2 Argentina Pediatric Perfusion Market
7.2.1 Argentina Pediatric Perfusion Market by End-use
7.2.2 Argentina Pediatric Perfusion Market by Product
7.3 UAE Pediatric Perfusion Market
7.3.1 UAE Pediatric Perfusion Market by End-use
7.3.2 UAE Pediatric Perfusion Market by Product
7.4 Saudi Arabia Pediatric Perfusion Market
7.4.1 Saudi Arabia Pediatric Perfusion Market by End-use
7.4.2 Saudi Arabia Pediatric Perfusion Market by Product
7.5 South Africa Pediatric Perfusion Market
7.5.1 South Africa Pediatric Perfusion Market by End-use
7.5.2 South Africa Pediatric Perfusion Market by Product
7.6 Nigeria Pediatric Perfusion Market
7.6.1 Nigeria Pediatric Perfusion Market by End-use
7.6.2 Nigeria Pediatric Perfusion Market by Product
7.7 Rest of LAMEA Pediatric Perfusion Market
7.7.1 Rest of LAMEA Pediatric Perfusion Market by End-use
7.7.2 Rest of LAMEA Pediatric Perfusion Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 LivaNova PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 BL Lifesciences (BL group of family companies)
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Cardinal Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 SWOT Analysis
8.6 EUROSETS S.R.L. (GVM Care Research)
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Getinge AB
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Koninklijke Philips N.V.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.8.6 SWOT Analysis
8.9 Nonin Medical, Inc.
8.9.1 Company Overview
8.10. GE HealthCare Technologies, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 